ClinicalTrials.Veeva

Menu

Effect of Corticosteroid Injections on Blood Glucose (CSI)

Duke University logo

Duke University

Status and phase

Suspended
Phase 2

Conditions

Shoulder Osteoarthritis
Hip Osteoarthritis
Diabetes Mellitus
Steroid Diabetes
Knee Osteoarthritis
Adhesive Capsulitis

Treatments

Drug: Dexamethasone 4mg
Drug: Kenalog 40 MG
Drug: Celestone
Drug: Depo-medrol

Study type

Observational

Funder types

Other

Identifiers

NCT05048264
Pro00108093

Details and patient eligibility

About

The purpose of this study is to measure the effect of various corticosteroids administered to the shoulder, knee and hip joints in diabetic patients on resultant blood glucose readings.

Full description

The purpose of this study is to measure the effect of various corticosteroids administered to the shoulder, knee, and hip joints in diabetic patients on resultant blood glucose readings.

Corticosteroid injections (CSI) are frequently used in orthopedic settings in order to treat a wide array of orthopedic issues, including osteoarthritis, bursitis, tendinitis, and many others. The effect of diabetes on the musculoskeletal system and its role in orthopedic disease has been well-documented. Current evidence demonstrates that corticosteroids, even when administered through a local musculoskeletal injection, can lead to temporary increases in blood glucose. Ultrasound guidance was not explicitly used in any of the studies examining the impact of steroids on blood glucose. The utilization of ultrasound guidance has been shown to increase accuracy when performing injections into the subacromial space as well as the glenohumeral joint when compared to palpation/landmark-guided injections.

Enrollment

55 estimated patients

Sex

All

Ages

40 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Known diabetic patients ages 40-75 undergoing clinically indicated standard of care corticosteroid shoulder, knee and hip joint injection
  • Ability to perform daily blood glucose testing
  • Can receive and send text messages

Exclusion criteria

  • Previous joint arthroplasty
  • Corticosteroid injection at other sites in the body within the past month
  • Systemic corticosteroid within the last month other than asthma inhaler
  • Anyone who are unable to read and/or understand English
  • Pregnant women (self-report)

Trial design

55 participants in 1 patient group

Diabetic patients receiving a corticosteroid injection of their shoulder, knee or hip joints.
Description:
There are no study-related interventions for this study.

Trial contacts and locations

1

Loading...

Central trial contact

Duke Sports Medicine Research

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems